Deploying vibration-controlled transient elastography/controlled attenuation parameter devices at the population level is a financially advantageous solution to address the epidemic of fatty liver disease.
Andrew Mackenzie, BS
Advertisement
Articles by Andrew Mackenzie, BS
Advertisement
Latest Updated Articles
- Population-Based Return on Investment of Deploying Transient Elastography
Published: May 28th 2021 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
2
GLP-1 Receptor Agonists May Improve Rheumatoid Arthritis Symptoms
3
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
4
Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD
5
